fbpx

SOCIAL MEDIA INFLUENCERS

The rise of ‘patient influencers’ throws up medical pros and cons

By our News Team | 2022

Non-expert influencers may be the next frontier of direct-to-consumer pharmaceutical marketing, say experts.

“OMG. Have you guys heard about this?” So began a 2015 post by then-pregnant celebrity influencer Kim Kardashian, singing the praises of a #morningsickness drug called Diclegis to her tens of millions of followers on Instagram.

“It’s been studied and there’s no increased risk to the baby,” she wrote, alongside a smiling selfie of her holding the pill bottle. “I’m so excited and happy with the results.”

The Food and Drug Administration in the US swiftly flagged the post for omitting the drug’s long list of risks, required Kardashian to remove the post, and admonished the drug manufacturer with a warning letter.

But seven years later, the so-called ‘patient influencers’ are alive and well, with pharmaceutical companies increasingly partnering with real-life patients who share their personal stories and advocate for brands online.

Social Media Influencers

A screen shot of the since-deleted post by Kim Kardashian. Photo credit: University of Colorado, Boulder

This trend intrigues and concerns Erin Willis, an Associate Professor of Advertising, Public Relations and Media Design at the University of Colorado, Boulder. In a new paper, published in the Journal of Medical Internet Research, she calls on the academic community to take a closer look.

“This is a growing phenomenon, but there is virtually no research on it and very little regulation,” said Willis, who is interviewing dozens of patient influencers for a new study. “Is it going to help patients be better informed? Or is it going to get patients to ask their doctors for drugs they don’t really need? We just don’t know, because no one has studied it.”

In one of the first academic papers to date to explore the phenomenon, Willis and co-author Marjorie Delbaere, a Professor of Marketing at the University of Saskatchewan in Canada, framed patient influencers as “the next frontier in direct-to-consumer (DTC) pharmaceutical marketing.”

DTC pharmaceutical ads have exploded

The controversial form of marketing, legal only in the United States and New Zealand, enables drug companies to target consumers directly, rather than through physicians. Since the first DTC ad ran in the 1980s, the ads have exploded, leading patients to ask their doctors about drugs they see on TV or in print. As Willis notes, about 44% who ask their doctor about a drug, get it.

Today, with trust in pharmaceutical companies, doctors and traditional media all declining, drug makers are now turning to patients themselves as messengers, with companies like WEGO health connecting patient influencers to healthcare companies for paid partnerships.

Having learned from the Kardashian incident, many ad agencies now avoid celebrity influencers altogether and instead engage micro-influencers like individual patients who share their personal stories and endorsements in condition-specific support groups (diabetes, heart disease, etc.) or those with a niche social media following.

“It’s a lot like what we used to see with doctors and pharmaceutical companies,” said Willis. “Only now it is patients using social media to advocate for disease awareness and, in some cases, pharmaceutical medications.”

The US Federal Trade Commission (FTC) now requires that patient influencers disclose whether they are being paid (influencers use #ad or #sponcon to alert followers). And the FDA has published rules about what can and cannot be said on social posts. 

But such rules are open to interpretation and hard to enforce, said Willis. The authors also have concerns that a blurring of the lines between ad and opinion could potentially deceive patients.

“When you see an ad and you recognise it as such, you are aware of the intent and you process it differently,” said Delbaere.

But Willis also sees many upsides to the patient influencer revolution. Patients often know more than their doctors about what it’s like to experience a health condition, and sharing that expertise can potentially help other patients discover treatments they’re unaware of.

And unlike other forms of DTC advertising, social media is interactive. “If an influencer recommends a drug, there is an entire community of voices that get to weigh in on it and support it or share their negative experiences,” noted Willis.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop

    Dr Kin Kariisa

    Group CEO - Next Media

    Dr. Kin Kariisa is an extraordinary force at the helm of Next Media Services, a conglomerate encompassing NBS TV, Nile Post, Sanyuka TV, Next Radio, Salam TV, Next Communication, Next Productions, and an array of other influential enterprises. His dynamic role as Chief Executive Officer exemplifies his unwavering commitment to shaping media, business, and community landscapes.
    With an esteemed academic journey, Dr. Kariisa’s accolades include an Honorary PhD in exemplary community service from the United Graduate College inTexas, an MBA from United States International University in Nairobi, Kenya, a Master’s degree in Computer Engineering from Huazong University in China, and a Bachelor’s degree in Statistics from Makerere University.
    Dr. Kariisa pursued PhD research in Computer Security and Identity Management at Security of Systems Group, Radboud University in Nijmegen, Netherlands. As a dynamic educator, he has shared his expertise as a lecturer of e-Government and Information Security at both Makerere University and Radboud University.

    Dr Kin did his PhD research in Computer Security and Identity Management at Security of Systems Group, Radbond University in Nigmegen, Netherlands. He previously served as a lecturer of e-Government and Information Security at Makerere University in Kampala, Uganda and Radbond University in Netherlands.

    Dr Kin did his postgraduate courses in Strategic Business Management, Strategic Leadership Communication and Strategies for Leading Successful Change Initiatives at Harvard University, Boston USA.

    • Other current and previous roles played by Dr Kin Kariisa:
    • Lecturer of e-Government and Information Security to graduate students at Makerere University, Kampala and Radbond University in the Netherlands
    • Director of Eco Bank Uganda Limited, one of the largest banks in Africa
    • Chairman of the National Association of Broadcasters, an umbrella industry association for all Television, Radio and online broadcasters in Uganda.
    • Chairman of Board of Directors of Nile Hotel International, that owns the leading hotel in Uganda, Kampala Serena Hotel.
    • Chairman of Board of Directors of Soliton Telmec Uganda, the leading telecom company in Optic fibre business managing over 80% of optic fibre in Uganda.